Tymedika S.r.l.

Corporate disclosure pursuant to Art. 25, paragraph 11 of Decree-Law 179/2012 (Special Section for Innovative Startups)

In compliance with the Italian Innovative Startup Law, the official data below — extracted from the deed of incorporation, the latest filed financial statements, and the records of the Milan Monza Brianza Lodi Chamber of Commerce — is published in an open, tabular and reusable format.

Section / Regulatory Requirement	Official Company Information
a) Date and place of incorporation, name and address of the notary	The company was incorporated on January 30, 2025 in Milan. Deed of incorporation reference: Register no. 5479 – Collection no. 4080. Notary: Dott. Francesco Pallino, office at Viale Luigi Majno n. 28, 20129 – Milan.
b) Main office and any branch offices	Registered office: Via Gerolamo Gaslini n. 1 – 20900 Monza (MB), Italy. Branch offices / Local units: None (the company operates exclusively from its registered office, as confirmed by the Companies Register).
c) Corporate purpose (Summary of technological and innovative activities)	The company's purpose is the development, production and commercialization of innovative products or services with high technological value. Primarily: research into innovative solutions in the medical field (both human and veterinary) aimed at improving therapeutic outcomes and reducing patient treatment and rehabilitation times; the development, production, sale and rental of medical devices, instruments, tools and specialized equipment for operating rooms and laboratories through feasibility studies, experimental development, prototyping and patent validation; the development of proprietary applied algorithms and software.
d) Activities carried out and research and development expenses	Tymedika S.r.l. operates in the field of experimental research and development in other natural sciences and engineering (primary ATECO Code: 72.19.09). Research and Development Expenses: For the purposes of registration and maintenance of the Special Section, against total production costs of €30,000.00, the company allocated and invested a total of €22,500.00 in R&D (equal to 75% of production value, well above the 15% minimum threshold set by law). The expenses were mainly allocated to regulatory development, medical device certifications, clinical market analysis, and industrial start-up costs.
e) List of shareholders (Transparency – Decree-Law No. 179/2012)	The share capital is €10,000.00, fully subscribed and paid in equal shares solely by natural persons (with no intermediation by fiduciary companies or external holding entities): Eng. Cerini Aleardo (Nominal share: €2,500.00 – 25% ownership) Dr. Cerini Riccardo (Nominal share: €2,500.00 – 25% ownership) Eng. De Lorenzo Domenico (Nominal share: €2,500.00 – 25% ownership) Avv. Colace Elisabetta (Nominal share: €2,500.00 – 25% ownership)
f) List of subsidiary companies	None. The company does not hold shares, stock, or equity interests in other companies.
g) Educational qualifications and professional experience of shareholders and staff	Eng. Aleardo Cerini (Sole Director): Degree in Electronic Engineering with a specialization in Bioengineering (Politecnico di Milano, 1991). Thirty years of experience as Commercial Process Manager and Sales Excellence Manager in the joint prosthetics and traumatology sector (Smith & Nephew, Celbio). Eng. Domenico De Lorenzo (R&D Director): Degree in Electronic Engineering (University of Pisa, 1996) and PhD in Bioengineering. Twenty years of experience in clinical development, scientific research, and technical-patent management of medical devices for orthopedic foot surgery. Avv. Elisabetta Colace: Law degree (University of Pisa, 2000). Extensive experience in Credit Risk Management, international contract management, and tender procedures for medical equipment and gases. Dr. Riccardo Cerini: Bachelor's degree in Sports Sciences (Università Telematica Pegaso) and student at the Faculty of Physiotherapy, University of Milano-Bicocca.
h) Professional, collaborative or commercial relationships	An active technical-scientific collaboration is in place with Prof. Giuseppina Ambrogio, Associate Professor of Manufacturing Technologies and Systems at the Department of Mechanical, Energy and Management Engineering of the University of Calabria (formalized through a dedicated cooperation agreement).
i) Industrial and intellectual property rights	The company holds 100% exclusive ownership of the following title registered and filed with the Italian Patent and Trademark Office (UIBM): Type: Utility Model Patent Application Number: 202025000001515 Filing Date: 09/04/2025 Title of Invention: Adjustable guide for percutaneous surgery P.G.S. Designated Inventor: Eng. Domenico De Lorenzo International Classification: A61B 17/56
j) Latest filed annual financial statements	On 05/26/2026 the company officially filed its first annual financial statements (abbreviated Micro-enterprise financial statements closed as of 12/31/2025), registered under Filing Protocol No. 350030/2026. At the same time, the company filed the Declaration of Compliance and Maintenance of Innovative Startup Requirements for 2026. The relevant financial documents and the structured XBRL file are freely available on the Companies Register portal.

Chamber of Commerce Transparency Identifiers

Tax Code / VAT Number 13982180963

Companies Register Listing Special Section for Innovative Startups – Milan Monza Brianza Lodi Chamber of Commerce

REA Number MB-2755440

Share Capital €10,000.00 fully paid-in

Institutional Certified Email (PEC) tymedika@pec.it

Official Website www.tymedika.com